Prospective evaluation of automatized PF4/heparin immunoassays HemosIL HIT-ab (PF4-H) for the diagnosis of heparin-induced thrombocytopenia

Int J Lab Hematol. 2015 Apr;37(2):244-52. doi: 10.1111/ijlh.12275. Epub 2014 Jul 15.

Abstract

Introduction: Recently, rapid immunoassays have been developed to allow the detection of antibodies anti-PF4/heparin. In this prospective study, we evaluated the performances of a automatized immunoassay (HemosIL HIT-Ab) in comparison with an ELISA (Zymutest HIA IgG) used for the diagnosis of heparin-induced thrombocytopenia (HIT) in association with the 4T's score.

Methods: According to the 4T's score, samples with score ≤3 had no further analysis. Two immunological assays Zymutest HIA IgG and HemosIL HIT-Ab were performed in samples with score ≥4. In patients with at least one positive immunological assay or two negative immunological assays but with high-pretest probability (4T's score ≥6), HIT was screened by one functional assay using washed platelets.

Results: The sensitivities of both assays were excellent and comparable (100%). The specificity was 92.3% for ELISA and 91.2% for HemosIL HIT-Ab. The analysis of the operating characteristics showed that both assays have almost identical ROCs (AUROC, 0.9951 and 0.9853, respectively, for ELISA and HemosIL HIT-Ab) and the calculating of the κ coefficient revealed a good agreement (0.67).

Conclusion: Performance characteristics of the HemosIL HIT-Ab are comparable to the Zymutest HIA IgG. The HemosIL HIT-Ab can be used in association with the 4T's score to rule out HIT.

Keywords: ELISA; HIT antibodies; Heparin-induced thrombocytopenia; immunoassay.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies / blood
  • Antibodies / immunology
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Heparin / adverse effects*
  • Heparin / immunology
  • Humans
  • Immunoassay / instrumentation
  • Immunoassay / methods*
  • Immunoassay / standards
  • Male
  • Middle Aged
  • Platelet Factor 4 / immunology
  • Reproducibility of Results
  • Sensitivity and Specificity
  • Thrombocytopenia / diagnosis*
  • Thrombocytopenia / etiology*
  • Young Adult

Substances

  • Antibodies
  • Platelet Factor 4
  • Heparin